secwatch.observer — SEC 8-K summary
======================================

Issuer:     FEMASYS INC (FEMY)
CIK:        0001339005
Form:       8-K
Filed at:   2024-08-29T23:59:59+00:00
Accession:  0001140361-24-039138
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Femasys receives CE Mark and Health Canada approval for FemVue MINI fallopian tube assessment
--------------------------------------------------------------------------------

- CE Mark certification obtained for FemVue MINI, enabling sales in European Economic Area.
- Health Canada granted product approval for FemVue MINI, opening Canadian market.
- FemVue MINI is a compact, eco-friendly version of existing FemVue diagnostic product.
- CEO Kathy Lee-Sepsick cites expanded access to advanced women's health diagnostics in Europe and Canada.
- Product designed with smaller environmental footprint, supporting company sustainability initiatives.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124039138/0001140361-24-039138-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1339005/000114036124039138/ef20035123_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-039138

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer